BioCytics Inc
John Powderly II MD is the Founder & President of Carolina BioOncology Institute, where he oversees an oncology medical practice, phase 1 cancer research clinic, research laboratory, and cell manufacturing facility. Additionally, he is the Founder & CEO of BioCytics Inc. John also serves as an Adjunct Clinical Assistant Professor of Medicine at UNC School of Medicine and an Adjunct Consulting Clinical Assistant Professor of Medicine at Duke University Medical Center. Prior to this, he held various clinical and faculty positions at MD Anderson Cancer Center, UTHealth Houston, and the National Cancer Institute. He completed his medical oncology fellowship at the University of North Carolina at Chapel Hill School of Medicine and his combined medicine and pediatrics residency at UTHealth Houston. John earned his Doctor of Medicine from Georgetown University School of Medicine and his Bachelor’s Degree in Biology from George Mason University.
This person is not in any teams
BioCytics Inc
BioCytics via the Human Applications Lab is focused on bringing personalized oncology treatments to the market. BioCytics has an ongoing IRB-approved clinical trial (BioCytics 0001; NCT00571389) that allows for the collection and study of blood and tissue samples from consenting cancer patients. We are incubated within Carolina BioOncology - a preferred cancer treatment and Phase I drug testing facility. BioCytics was founded by Dr. John Powderly, MD, medical board certified oncologist and a certified physician investigator (CPI), who is also president of Carolina BioOncology Institute (CBOI).